X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (45483) 45483
Newspaper Article (779) 779
Newsletter (327) 327
Book Chapter (301) 301
Book / eBook (162) 162
Magazine Article (119) 119
Transcript (50) 50
Web Resource (13) 13
Conference Proceeding (9) 9
Reference (9) 9
Book Review (8) 8
Dissertation (6) 6
Publication (6) 6
Report (5) 5
Trade Publication Article (4) 4
Government Document (3) 3
Patent (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (35388) 35388
male (18600) 18600
female (17462) 17462
middle aged (11888) 11888
adult (10502) 10502
hematology (10408) 10408
animals (9484) 9484
aged (8797) 8797
risk factors (6117) 6117
peripheral vascular disease (5295) 5295
treatment outcome (5167) 5167
thrombosis (5092) 5092
blood (4848) 4848
surgery (4755) 4755
analysis (4294) 4294
care and treatment (4290) 4290
health aspects (4082) 4082
research (3866) 3866
anticoagulants (3744) 3744
anticoagulants - therapeutic use (3707) 3707
coagulation (3627) 3627
inflammation (3624) 3624
time factors (3585) 3585
blood coagulation - drug effects (3554) 3554
mortality (3492) 3492
medicine & public health (3446) 3446
patients (3370) 3370
adolescent (3358) 3358
proteins (3004) 3004
pharmacology & pharmacy (2949) 2949
plasma (2945) 2945
medicine (2923) 2923
aged, 80 and over (2913) 2913
retrospective studies (2812) 2812
therapy (2725) 2725
blood coagulation (2686) 2686
prospective studies (2666) 2666
mice (2653) 2653
blood platelets (2652) 2652
hemophilia (2620) 2620
cardiac & cardiovascular systems (2579) 2579
management (2549) 2549
child (2531) 2531
thrombin (2525) 2525
diagnosis (2418) 2418
risk (2411) 2411
young adult (2394) 2394
biomarkers - blood (2376) 2376
disease (2331) 2331
research article (2273) 2273
hemorrhage (2190) 2190
blood coagulation tests (2142) 2142
oncology (2117) 2117
medical research (2109) 2109
thromboembolism (2000) 2000
immunology (1994) 1994
rats (1990) 1990
cancer (1989) 1989
stroke (1984) 1984
prognosis (1948) 1948
pregnancy (1941) 1941
hemostasis (1938) 1938
studies (1934) 1934
activation (1927) 1927
platelets (1898) 1898
medicine, research & experimental (1891) 1891
multidisciplinary sciences (1870) 1870
drug therapy (1850) 1850
physiological aspects (1842) 1842
medicine, general & internal (1795) 1795
disease models, animal (1728) 1728
prevention (1726) 1726
blood transfusion (1721) 1721
expression (1701) 1701
review (1694) 1694
blood clot (1692) 1692
blood coagulation factor viii (1685) 1685
warfarin (1674) 1674
usage (1652) 1652
abridged index medicus (1634) 1634
biomarkers (1633) 1633
cell biology (1632) 1632
cardiology (1598) 1598
blood pressure (1595) 1595
recombinant proteins - therapeutic use (1594) 1594
pediatrics (1591) 1591
anticoagulants - adverse effects (1558) 1558
child, preschool (1558) 1558
cytokines (1558) 1558
sepsis (1558) 1558
blood coagulation factors - therapeutic use (1555) 1555
transplantation (1554) 1554
dose-response relationship, drug (1552) 1552
cardiovascular disease (1551) 1551
heparin - therapeutic use (1543) 1543
hypertension (1539) 1539
internal medicine (1482) 1482
medicine, experimental (1478) 1478
atherosclerosis (1472) 1472
science (1459) 1459
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (40) 40
Online Resources - Online (14) 14
Collection Dvlpm't (Acquisitions) - Vendor file (11) 11
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
St. Michael's Hospital - Stacks (2) 2
Toronto East General Hospital - Stacks (2) 2
Engineering & Comp. Sci. - Stacks (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Providence Healthcare - Stacks (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's Hospital - Reference (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Trillium Health Centre - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
Women's College Hospital - Reference (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (46026) 46026
German (576) 576
French (263) 263
Russian (210) 210
Japanese (149) 149
Spanish (100) 100
Italian (89) 89
Chinese (58) 58
Portuguese (49) 49
Polish (48) 48
Dutch (31) 31
Norwegian (18) 18
Czech (14) 14
Bulgarian (12) 12
Hungarian (12) 12
Danish (11) 11
Croatian (10) 10
Finnish (10) 10
Swedish (10) 10
Turkish (8) 8
Romanian (7) 7
Serbian (7) 7
Hebrew (4) 4
Ukrainian (4) 4
Arabic (3) 3
Lithuanian (3) 3
Slovenian (3) 3
Icelandic (1) 1
Korean (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thrombosis and Haemostasis, ISSN 0340-6245, 05/2008, Volume 99, Issue 5, pp. 840 - 850
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 9, pp. 809 - 818
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 07/2016, Volume 134, Issue 3, pp. 248 - 261
Vitamin K antagonists are commonly used by clinicians to provide anticoagulation to patients who have or are at risk of having thrombotic events. In addition... 
anticoagulants | atrial fibrillation | venous thromboembolism | hemorrhage | CARDIAC & CARDIOVASCULAR SYSTEMS | ACTIVATED FACTOR-VII | ATRIAL-FIBRILLATION | IN-VITRO | THROMBIN GENERATION | DABIGATRAN ETEXILATE | PROTHROMBIN COMPLEX CONCENTRATE | SYMPTOMATIC VENOUS THROMBOEMBOLISM | PRACTICAL MANAGEMENT | PERIPHERAL VASCULAR DISEASE | STAGE RENAL-DISEASE | FACTOR XA INHIBITOR | Recombinant Proteins - therapeutic use | Plasma | Dabigatran - adverse effects | Pyrazoles - therapeutic use | Humans | Hemorrhage - prevention & control | Recombinant Proteins - adverse effects | Thiazoles - therapeutic use | Factor VIIa - therapeutic use | Arginine - analogs & derivatives | Dabigatran - therapeutic use | Thiazoles - adverse effects | Pyridines - adverse effects | Rivaroxaban - adverse effects | Factor Xa - therapeutic use | Rivaroxaban - therapeutic use | Factor Xa - adverse effects | Pyrazoles - adverse effects | Pyridines - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Administration, Oral | Antithrombins - therapeutic use | Piperazines - therapeutic use | Dabigatran - antagonists & inhibitors | Piperazines - adverse effects | Factor Xa Inhibitors - therapeutic use | Hemorrhage - drug therapy | Antithrombins - adverse effects | Factor Xa Inhibitors - adverse effects | Blood Coagulation Factors - therapeutic use | Arginine - adverse effects | Pyridones - therapeutic use | Hemorrhage - chemically induced | Hemostatics - therapeutic use | Arginine - therapeutic use | Pyridones - adverse effects
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 06/2010, Volume 103, Issue 6, pp. 1116 - 1127
Journal Article
Journal of medicinal chemistry, ISSN 0022-2623, 12/2017, Volume 60, Issue 23, pp. 9703 - 9723
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 373, Issue 25, pp. 2413 - 2424
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 370, Issue 9585, pp. 439 - 448
Journal Article
Seminars in Immunopathology, ISSN 1863-2297, 1/2012, Volume 34, Issue 1, pp. 73 - 91
  Issue Title: Coagulation and Inflammation Sphingosine 1-phosphate (S1P) is a lipid mediator produced from sphingomyelin by the sequential enzymatic actions of sphingomyelinase, ceramidase, and sphingosine kinase... 
Biomedicine | Immunology | Vascular barrier integrity | G-protein-coupled receptor | Coagulation | Immune cell trafficking | Internal Medicine | Inflammation | Sphingosine 1-phosphate | RELAPSING MULTIPLE-SCLEROSIS | VASCULAR S1P GRADIENT | LIPID PHOSPHATE PHOSPHATASES | NECROSIS-FACTOR-ALPHA | IMMUNOLOGY | PATHOLOGY | LIQUID-CHROMATOGRAPHIC METHOD | BREAST-CANCER CELLS | CIRCULATING MATURE LYMPHOCYTES | PROTEIN-COUPLED RECEPTOR | ENDOTHELIAL-CELL CHEMOTAXIS | HIGH-DENSITY-LIPOPROTEINS | Inflammation - pathology | Receptors, Lysosphingolipid - antagonists & inhibitors | Lymph Nodes - pathology | Multiple Sclerosis - blood | Humans | Immunosuppressive Agents - therapeutic use | Tumor Necrosis Factor-alpha - blood | Inflammation - blood | Lysophospholipids - immunology | Neovascularization, Pathologic - blood | Neovascularization, Pathologic - pathology | Signal Transduction - immunology | Neoplasm Metastasis | Lymphocytes - immunology | Neoplasms - blood | Blood Coagulation - immunology | Inflammation - drug therapy | Propylene Glycols - therapeutic use | Tumor Necrosis Factor-alpha - immunology | Neovascularization, Pathologic - immunology | Receptors, Lysosphingolipid - metabolism | Lymphocytes - metabolism | Atherosclerosis - pathology | Atherosclerosis - drug therapy | Atherosclerosis - immunology | Fingolimod Hydrochloride | Lymph Nodes - metabolism | Sphingosine - immunology | Inflammation - immunology | Lysophospholipids - blood | Lymph Nodes - immunology | Neoplasms - drug therapy | Atherosclerosis - blood | Receptors, Lysosphingolipid - immunology | Lymphocytes - pathology | Sphingosine - analogs & derivatives | Animals | Signal Transduction - drug effects | Neoplasms - immunology | Neovascularization, Pathologic - drug therapy | Multiple Sclerosis - immunology | Sphingosine - blood | Sphingosine - therapeutic use | Neoplasms - pathology | Multiple Sclerosis - drug therapy | Enzymes | Multiple sclerosis | Lymphocytes | Sphingosine | Atherosclerosis | Metastasis | G protein-coupled receptors | sphingosine kinase | Central nervous system | Lipids | Cell surface | Ceramidase | Blood | Lymph nodes | Metastases | Sphingomyelin phosphodiesterase | Angiogenesis | Tumor necrosis factor | Arteriosclerosis | FTY720 | sphingomyelin | Lymph
Journal Article